PRESS RELEASES

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 20 2 1 Conference call and webcast on Tuesday, March 14, 2022 at 8:30am EDT / 1:30pm CET          Progress towards seeking approval of GRASPA® for the treatment of ALL patients with hypersensitivity to pegylated
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2022
              Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website :
View HTML
Toggle Summary ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases
ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases Cambridge, MA (U.S.) and Lyon (France), February 8 , 202 2 – ERYTECH Pharma (Euronext Paris : ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2022
                Monthly information related to total number of voting rights and shares composing the share capital – January 3 1 , 202 2 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Toggle Summary ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GI
ERYTECH Announces P resentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GI Interim results from the Phase 1 rESPECT trial of eryaspase plus mFOLFIRINOX as first-line treatment for advanced pancreatic cancer patients , presented in a poster presentation, confirm
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2021
                Monthly information related to total number of voting rights and shares composing the share capital – December 3 1 , 2021. Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Toggle Summary ERYTECH to Participate in the Upcoming January Virtual Investor Conferences
ERYTECH to Participate in the Upcoming January Virtual Investor Conferences Cambridge, MA (U.S.) and Lyon (France), January 3 , 202 2 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances
View HTML
Toggle Summary ERYTECH Announces $7.85 Million Registered Direct Offering
ERYTECH Announces $ 7.85 Million Registered Direct Offering Lyon (France) and Cambridge, MA (U.S.), December 14 , 202 1 – ERYTECH Pharma (Nasdaq & Euronext:   ERYP) (the “Company”) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug
View HTML
Toggle Summary ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI
ERYTECH Announces P resentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI Full results of the Expanded Access Program in ‘ Double Allergic ’ a cute l ymphoblastic l eukemia ( AL L ) patients were presented this weekend at ASH
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital – November 30, 2021
                Monthly information related to total number of voting rights and shares composing the share capital – November 3 0 , 2021. Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Top